linjc16/ctgov huggingface dataset:
Multicentre REtrospective StuDy of Treatment and OUtComes in STEMI Patients in Fujian Province

Study Overview
=================
Brief Summary
-----------------
This is a multicentre observational study planned to gather follow up data for a period of 1 year in order to understand the treatments and outcomes of ST-segment elevation myocardial infarction(STEMI) and improve medical care quality in Fujian province for China. Consecutive patients who were admitted and diagnosed with STEMI between January 2014 December 2018 were conducted at five regional representative hospitals in Fujian province, which included the Fujian Provincial Hospital,Longyan First Hospital, the affiliated hospital of putian university,the Second Affiliated Hospital of Fujian Medical University and Mindong Hospital of Ningde City.

Official Title
-----------------
Multicentre REtrospective StuDy of Treatment and OUtComes in ST-elevatION Myocardial Infarction(STEMI) Patients in Fujian Province

Conditions
-----------------
ST-segment Elevation Myocardial Infarction

Intervention / Treatment
-----------------
* Other: treatment and outcome


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: STEMI patients with symptom onset within 30 days Exclusion Criteria: -
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: treatment and outcome|nan|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| In-hospital mortality | all mortality,cardiovascular mortality | 5years | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| other in-hospital complications | recurrent myocardial infarction, target vessel revascularization,contrast-induced acute kidney injury,stroke,bleeding,and so on | 5years | 
| MACEs for long-term follow up | mortality,stent restenosis, recurrent myocardial infarction, and target vessel revascularization,stroke,bleeding,and so on | 1 year |
Ceres: Eating Habits Among Lebanese Nurses

Study Overview
=================
Brief Summary
-----------------
The main objective of this research is to study the impact of the health crisis and the economic situation in Lebanon on the eating habits of Lebanese nurses. It is a descriptive, study among Lebanese nurses working in hospitals. It will be a self-administered survey on eating habits and their relationship with coping strategies and economic level among nurses. Analyses will be carried out using Statistical Package for Social Sciences (SPSS) 21 software. The results of this study will make a unique and collective contribution to the areas of nursing management and the prevention of eating disorders among nurses.

Official Title
-----------------
Impact of the Health Crisis and the Economic Situation in Lebanon on the Eating Habits of Lebanese Nurses.

Conditions
-----------------
Eating Habits, Nurses

Intervention / Treatment
-----------------
* Other: Ceres


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: nurses working in hospitals Exclusion Criteria: Maternity leave Pregnancy
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: Ceres|This will be a self-administered survey on eating habits and their relationship to coping strategies and economic level among nurses.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Crowding index | Measure of socio-economic status widely used in socio-economic surveys, it will be calculated as the number of people living in the same house/number of rooms in the house (excluding kitchen and bathrooms). An index > 1 indicates an overcrowded house with few economic resources. | 2 month | 
| Food Frequency Questionnaire (FFQ) | questionnaire used to obtain frequency and, in some cases, portion size information about food and beverage consumption over a specified period of time, typically the past month or year | 2 month | 
| Brief Cope | The Brief-COPE is a self-assessment questionnaire designed to measure effective and ineffective ways of coping with a stressful life event. | 2 month |
Platelet Indices Could Predict Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic Patients

Study Overview
=================
Brief Summary
-----------------
Spontaneous bacterial peritonitis (SBP) is an ascitic fluid infection in cirrhotic patients

Detailed Description
-----------------
Platelet indices can be utilized as a non-invasive predictor of SBP.

Official Title
-----------------
Platelet Indices Could Predict Spontaneous Bacterial Peritonitis in Cirrhotic Ascitic Patients

Conditions
-----------------
Cirrhosis, Liver

Intervention / Treatment
-----------------
* Diagnostic Test: Platelet indices


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Cirrhotic patients and ascites Exclusion Criteria: patients with ascites due to causes other than cirrhosis- immunocompromised patients, patients with abnormal thrombocytes due to non-hepatic causes.
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Cirrhotic ascitic patients with SBP,<br>Cirrhotic ascitic patients with SBP, | Diagnostic Test: Platelet indices<br>* MPV, PDW<br>|
| cirrhotic ascitic patients without SBP,<br>cirrhotic ascitic patients without SBP, | Diagnostic Test: Platelet indices<br>* MPV, PDW<br>|
| Healthy volunteers<br>Healthy individuals | Diagnostic Test: Platelet indices<br>* MPV, PDW<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Number of patients with SBP and abnormal platelet indices | Number of patients with SBP and abnormal platelet indices | 6 months |
Rapid Sequence Induction EU: Electronic Survey (RSIEU)

Study Overview
=================
Brief Summary
-----------------
Rapid sequence induction (RSI) is a common part of routine anesthesiology practice. However several steps of RSI are not based on evidence based data (EBM) and are considered controversial. In an electronic evaluation form that will be send to European Society of Anaesthesiology (ESA) members. The electronic survey will contain 22 question (11 for adult RSI and 11 for paediatric RSI). In the questionnaire the participants will have to describe their routine clinical practice in performing rapid sequence induction.

Detailed Description
-----------------
Rapid sequence induction (RSI) is a common part of routine anesthesiology practice. However several steps of RSI are not based on evidence based data (EBM) and are considered controversial. In an electronic evaluation form that will be send to European Society of Anaesthesiology (ESA) members. The electronic survey will contain 22 question (11 for adult RSI and 11 for paediatric RSI). In the questionnaire the participants will have to describe their routine clinical practice in performing rapid sequence induction. The 11 will be consulted with the research committee of ESA.

Official Title
-----------------
Rapid Sequence Induction in EU: Electronic Survey

Conditions
-----------------
Rapid Sequence Induction

Intervention / Treatment
-----------------
* Other: questionnaire


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: - Members of European Society of Anaesthesiology Exclusion Criteria: - not members of ESA

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 99 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: questionnaire|Members of European society of anaesthesiology care will obtain an electronic survey considering their clinical practice in RSI|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| RSI practice in European countries - questionnaire (electronic survey) | Evaluation of the clinical practice of the RSI European countries | 2 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
crush induction, RSI
Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index

Study Overview
=================
Brief Summary
-----------------
In this study; We aimed to investigate the role of pleth variability index, which is a noninvasive method, in showing fluid response in SARS-CoV-2 (COVID-19) patients, which we know is appropriate fluid management.

Official Title
-----------------
Evaluation of the Fluid Response of SARS-CoV-2 (COVID-19) Patients in Intensive Care; Pleth Variability Index

Conditions
-----------------
Pleth Variability Index

Intervention / Treatment
-----------------
* Diagnostic Test: Pleth variability index


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patients hospitalized in COVID 19 anesthesia intensive care unit Patients over the age of 18 Exclusion Criteria: Patients under the age of 18

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Pleth variability index<br>Patients undergoing fluid management with Pleth variability index | Diagnostic Test: Pleth variability index<br>* The usefulness of Pleth variability index in predicting fluid response in patients with COVID 19<br>|
| hemodynamic<br>Patients undergoing fluid management with hemodynamic findings | Diagnostic Test: Pleth variability index<br>* The usefulness of Pleth variability index in predicting fluid response in patients with COVID 19<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Pleth variability index | Pleth variability index levels | 1 month |
Small and Steatotic Hepatocellular Carcinoma

Study Overview
=================
Brief Summary
-----------------
Percutaneous thermoablation in an effective local curative treatment in patients with cirrhosis and HCC smaller than 3 cm in diameter (BCLC 0-A). Around 30% of HCC patients referred for percutaneous ablation were regarded as non-feasible because of a difficult-at risk location or undetectable nodules. We used percutaneous thermoablation to treat HCC on high risk locations (subcapsular or liver dome) with or without lipiodol marked (for undetectable HCC). No clinical study has been published so far to compare percutaneous thermoablation of HCC on liver dome CT guided with artificial pneumothorax and lipiodol marked, and percutaneous thermoablation of HCC guided by ultrasonography (non subcapsular, distent form diaphragm). This retrospective study evaluate the overall survival, the local tumor progression or distant liver progression after percutaneous ablation for HCC and determine prognostic factors.

Detailed Description
-----------------
We performed 412 percutaneous thermoablations on 238 patients for HCC between January 2015 and November 2019. All thermoablation procedures were performed percutaneously under ultrasound or CT guidance, with ou without artificial pneumothorax or ascites, with ou without lipiodol marked. Purposes: Tumor response upon mRECIST criteria Progression-free survival Overall survival Local tumor progression Distent liver progression Prognostic factors

Official Title
-----------------
Small and Steatotic Hepatocellular Carcinoma : a Distinctive Radiological Variant With Improved Outcome After Percutenous Ablation

Conditions
-----------------
HCC

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion criteria: HCC according to histological examination or Barcelona criteria BCLC0 or A Measurable targets according to mRECIST v1.1 Child A or B7 cirrhosis HCC < 4 cm, < 3 nodules, Age ≥ 18 years No extrahepatic metastasis, no vascular invasion Performance status 0 or 1 Thrombocytes ≥ 50 000/mm3, TP > 50% Exclusion criteria: Follow-up < 1month Lobar/main portal venous thrombus Abundant ascites Antecedent of bilio-digestive anastomosis or endoscopic sphincterotomy Combined treatment with embolization or chemo-embolization

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Thermal ablations | Evaluation of thermal ablations (radiofrequency and microwave ablation) | 1 day | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Microwave ablation, Percutaneous thermalablation, High risk location, Articifial pneumothorax, Lipiodol marked, Prognostic factor
Virtual Reality Relaxation for Addiction Inpatients

Study Overview
=================
Brief Summary
-----------------
This trial examines the immediate session effect of Virtual Reality (VR) relaxation, when used at an addiction inpatient ward for adolescents.

Detailed Description
-----------------
Past research has revealed that Virtual Reality nature environments can be used to induce relaxation, yet this type of intervention has not yet been evaluated in a clinical setting. This trial examines whether VR relaxation can be used as a digital equivalent of a (physical) comfort room at an an addiction inpatient ward for adolescents.

Official Title
-----------------
Virtual Reality Relaxation at an Adolescent Addiction Inpatient Ward: A Single-arm Pilot Trial

Conditions
-----------------
Addiction

Intervention / Treatment
-----------------
* Behavioral: CalmPlace


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Patient at Maria Ungdom inpatient ward. Sufficient grasp of Swedish to understand terms of study participation and intervention instructions. Exclusion Criteria: Self-reported stereoscopic vision or balance problems hindering VR experience. Self-reported history of repeated violent outbursts when using technology.

Ages Eligible for Study
-----------------
Minimum Age: 15 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Intervention Model: Single Group Assignment
Interventional Model Description: Single-arm, with immediate effects of interest. Varying number of intervention uses across participants.
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Virtual Reality relaxation<br>Participants may request to use the application at any time during their stay at the ward, as many times as they wish. Participants sign in using an anonymous study ID and sessions (and outcomes) are automatically logged by the device to this ID. | Behavioral: CalmPlace<br>* Self-contained VR application allowing the user to build and custom a relaxation session, with options to vary session length (9-20 minutes), music/sound, relaxation exercises, and specific nature environment (three available) including time of day and events (e.g. rain). Delivered using an Oculus Go devices in kiosk-mode.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Change from baseline in general well-being | Rated 0-100 using a visual analogue scale with smiley-type anchors (higher score is better outcome). | Change from baseline (start of session) to immediately after the intervention | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Virtual Reality, Relaxation
Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial Lesions

Study Overview
=================
Brief Summary
-----------------
Human papillomavirus (HPV) infection plays a key role in the carcinogenesis of cervical cancer and pre-invasive lesions. There are hundred types of HPV, including high risk and low risk types, and it is proved the close association between the cervical cancer and high risk HPV. While HPV 16 and 18 are known to be the leading two genotypes detected in women with cervical neoplasm worldwide, there is considerable difference in the other prevalent high risk genotypes in different geographic areas. It is important to establish the local database about the cervical intraepithelial lesions and the related prevalent HPV genotypes. The investigators designed a retrospective study which included total 784 patients managed at our hospital from January 1, 2000 to December 31, 2007. The present study was to investigate the HPV genotypes in the Taiwanese female patients with abnormal cervical cytology and analyses the association between HPV types and cervical pre-invasive lesions. It could provide the guide for the clinicians in the management of patients with abnormal cytological change of Pap smear.

Official Title
-----------------
Retrospective Study of the Relationship Between Human Papillomavirus Genotype and Cervical Epithelial Lesions

Conditions
-----------------
Cervical Cancer

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Healthy volunteers People infected with HPV type 16 but without CIN lesions Patients with CIN lesions Patients with cervical cancer from National Taiwan University Hospital Informed consent is obtained, and the protocols are reviewed and approved by the appropriate Investigative Review Boards. Exclusion Criteria: None

Ages Eligible for Study
-----------------
Minimum Age: 20 Years
Maximum Age: 80 Years

Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| overall survival |  | from disease diagnosis to death |
Comparison of Perioperative Outcomes of Three Different Instruments in Total Laparoscopic Hysterectomy

Study Overview
=================
Brief Summary
-----------------
There are many instruments with different energy modalities or with different properties that are available for use in total laparoscopic hysterectomy. The aim of the present study is to compare three of these instruments that are present in our clinic - HALO PKS Cutting Forceps, LigaSure and Enseal Tissue Sealer, in total laparoscopic hysterectomy with respect to operation time, blood loss, change in hemoglobin / hematocrit levels, perioperative complications, return of gastrointestinal activity and hospitalization time.

Official Title
-----------------
Comparison of the Use of LigaSure, Halo PKS Cutting Forceps and Enseal Tissue Sealer in Total Laparoscopic Hysterectomy: a Randomised Trial.

Conditions
-----------------
Perioperative Outcomes

Intervention / Treatment
-----------------
* Device: Advanced bipolar devices


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: any women with the indication of hysterectomy Exclusion Criteria: malignancy having 3 or more previous abdominal surgeries uterus being larger than 12 weeks of gestation patients who must undergo additional surgical procedures during the same operation
Sexes Eligible for Study
-----------------
Female

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Active Comparator: LigaSure (advanced bipolar device)<br>Laparoscopic hysterectomy will be done with LigaSure in 15 patients. | Device: Advanced bipolar devices<br> <br> * Other names: EnSeal;|
| Active Comparator: Halo PKSforceps(advanced bipolar device)<br>Laparoscopic hysterectomy will be done with Halo PKS cutting forceps in 15 patients. | Device: Advanced bipolar devices<br> <br> * Other names: EnSeal;|
| Active Comparator: EnSeal (advanced bipolar device)<br>Laparoscopic hysterectomy will be done with EnSeal in 15 patients. | Device: Advanced bipolar devices<br> <br> * Other names: EnSeal;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Perioperative Outcomes | Perioperative outcomes will be assessed with respect to complication rates, operation time, blood loss, change in hemoglobin and hemotocrit levels, time to return of gastrointestinal function and hospitalization time. | Until 45 patients are operated (6 months anticipated) | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
EnSeal, Halo PKS Cutting forceps, electrothermal bipolar vessel sealer, total laparoscopic hysterectomy, LigaSure, advanced bipolar device